403 related articles for article (PubMed ID: 29321042)
1. Type I IFN signature in childhood-onset systemic lupus erythematosus: a conspiracy of DNA- and RNA-sensing receptors?
Wahadat MJ; Bodewes ILA; Maria NI; van Helden-Meeuwsen CG; van Dijk-Hummelman A; Steenwijk EC; Kamphuis S; Versnel MA
Arthritis Res Ther; 2018 Jan; 20(1):4. PubMed ID: 29321042
[TBL] [Abstract][Full Text] [Related]
2. TBK1: A key regulator and potential treatment target for interferon positive Sjögren's syndrome, systemic lupus erythematosus and systemic sclerosis.
Bodewes ILA; Huijser E; van Helden-Meeuwsen CG; Tas L; Huizinga R; Dalm VASH; van Hagen PM; Groot N; Kamphuis S; van Daele PLA; Versnel MA
J Autoimmun; 2018 Jul; 91():97-102. PubMed ID: 29673738
[TBL] [Abstract][Full Text] [Related]
3. Contrasting expression pattern of RNA-sensing receptors TLR7, RIG-I and MDA5 in interferon-positive and interferon-negative patients with primary Sjögren's syndrome.
Maria NI; Steenwijk EC; IJpma AS; van Helden-Meeuwsen CG; Vogelsang P; Beumer W; Brkic Z; van Daele PL; van Hagen PM; van der Spek PJ; Drexhage HA; Versnel MA
Ann Rheum Dis; 2017 Apr; 76(4):721-730. PubMed ID: 27672125
[TBL] [Abstract][Full Text] [Related]
4. Hyperresponsive cytosolic DNA-sensing pathway in monocytes from primary Sjögren's syndrome.
Huijser E; Bodewes ILA; Lourens MS; van Helden-Meeuwsen CG; van den Bosch TPP; Grashof DGB; van de Werken HJG; Lopes AP; van Roon JAG; van Daele PLA; Brkic Z; Dik WA; Versnel MA
Rheumatology (Oxford); 2022 Aug; 61(8):3491-3496. PubMed ID: 35022662
[TBL] [Abstract][Full Text] [Related]
5. Monocyte surface expression of Fcgamma receptor RI (CD64), a biomarker reflecting type-I interferon levels in systemic lupus erythematosus.
Li Y; Lee PY; Kellner ES; Paulus M; Switanek J; Xu Y; Zhuang H; Sobel ES; Segal MS; Satoh M; Reeves WH
Arthritis Res Ther; 2010; 12(3):R90. PubMed ID: 20478071
[TBL] [Abstract][Full Text] [Related]
6. Expression of Long Interspersed Nuclear Element 1 Retroelements and Induction of Type I Interferon in Patients With Systemic Autoimmune Disease.
Mavragani CP; Sagalovskiy I; Guo Q; Nezos A; Kapsogeorgou EK; Lu P; Liang Zhou J; Kirou KA; Seshan SV; Moutsopoulos HM; Crow MK
Arthritis Rheumatol; 2016 Nov; 68(11):2686-2696. PubMed ID: 27338297
[TBL] [Abstract][Full Text] [Related]
7. Cell-specific type I IFN signatures in autoimmunity and viral infection: what makes the difference?
Kyogoku C; Smiljanovic B; Grün JR; Biesen R; Schulte-Wrede U; Häupl T; Hiepe F; Alexander T; Radbruch A; Grützkau A
PLoS One; 2013; 8(12):e83776. PubMed ID: 24391825
[TBL] [Abstract][Full Text] [Related]
8. RIG-I-like receptors and autoimmune diseases.
Kato H; Fujita T
Curr Opin Immunol; 2015 Dec; 37():40-5. PubMed ID: 26530735
[TBL] [Abstract][Full Text] [Related]
9. Expression of an anti-RNA autoantibody in a mouse model of SLE increases neutrophil and monocyte numbers as well as IFN-I expression.
Han JH; Umiker BR; Kazimirova AA; Fray M; Korgaonkar P; Selsing E; Imanishi-Kari T
Eur J Immunol; 2014 Jan; 44(1):215-26. PubMed ID: 24105635
[TBL] [Abstract][Full Text] [Related]
10. Identification of key interferon-stimulated genes for indicating the condition of patients with systemic lupus erythematosus.
Shen M; Duan C; Xie C; Wang H; Li Z; Li B; Wang T
Front Immunol; 2022; 13():962393. PubMed ID: 35967341
[TBL] [Abstract][Full Text] [Related]
11. Cluster of highly expressed interferon-stimulated genes associate more with African ancestry than disease activity in patients with systemic lupus erythematosus. A systematic review of cross-sectional studies.
Siddiqi KZ; Wilhelm TR; Ulff-Møller CJ; Jacobsen S
Transl Res; 2021 Dec; 238():63-75. PubMed ID: 34343626
[TBL] [Abstract][Full Text] [Related]
12. [Interferon-inducible genes lymphocyte antigen 6 complex E and tetratricopeptide repeats 1 are correlated with clinical features of patients with systemic lupus erythematosus].
Tang JP; Gu YY; Shen N; Ye S; Qian J; Hua J; Chen XG; Chen SL; Bao CD; Wang Y; Zhang W
Zhonghua Yi Xue Za Zhi; 2004 Jul; 84(14):1157-60. PubMed ID: 15387975
[TBL] [Abstract][Full Text] [Related]
13. Enhanced IFN-α production is associated with increased TLR7 retention in the lysosomes of palasmacytoid dendritic cells in systemic lupus erythematosus.
Murayama G; Furusawa N; Chiba A; Yamaji K; Tamura N; Miyake S
Arthritis Res Ther; 2017 Oct; 19(1):234. PubMed ID: 29052537
[TBL] [Abstract][Full Text] [Related]
14. Higher activation of the interferon-gamma signaling pathway in systemic lupus erythematosus patients with a high type I IFN score: relation to disease activity.
Liu M; Liu J; Hao S; Wu P; Zhang X; Xiao Y; Jiang G; Huang X
Clin Rheumatol; 2018 Oct; 37(10):2675-2684. PubMed ID: 29774490
[TBL] [Abstract][Full Text] [Related]
15. A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll-like receptor agonists.
York MR; Nagai T; Mangini AJ; Lemaire R; van Seventer JM; Lafyatis R
Arthritis Rheum; 2007 Mar; 56(3):1010-20. PubMed ID: 17328080
[TBL] [Abstract][Full Text] [Related]
16. Association of TLR7 copy number variation with susceptibility to childhood-onset systemic lupus erythematosus in Mexican population.
García-Ortiz H; Velázquez-Cruz R; Espinosa-Rosales F; Jiménez-Morales S; Baca V; Orozco L
Ann Rheum Dis; 2010 Oct; 69(10):1861-5. PubMed ID: 20525845
[TBL] [Abstract][Full Text] [Related]
17. microRNA downregulation in plasmacytoid dendritic cells in interferon-positive systemic lupus erythematosus and antiphospholipid syndrome.
van den Hoogen LL; Rossato M; Lopes AP; Pandit A; Bekker CPJ; Fritsch-Stork RDE; van Roon JAG; Radstake TRDJ
Rheumatology (Oxford); 2018 Sep; 57(9):1669-1674. PubMed ID: 29873766
[TBL] [Abstract][Full Text] [Related]
18. PTPN22 Variant R620W Is Associated With Reduced Toll-like Receptor 7-Induced Type I Interferon in Systemic Lupus Erythematosus.
Wang Y; Ewart D; Crabtree JN; Yamamoto A; Baechler EC; Fazeli P; Peterson EJ
Arthritis Rheumatol; 2015 Sep; 67(9):2403-14. PubMed ID: 26018863
[TBL] [Abstract][Full Text] [Related]
19. MxA as a clinically applicable biomarker for identifying systemic interferon type I in primary Sjogren's syndrome.
Maria NI; Brkic Z; Waris M; van Helden-Meeuwsen CG; Heezen K; van de Merwe JP; van Daele PL; Dalm VA; Drexhage HA; Versnel MA
Ann Rheum Dis; 2014 Jun; 73(6):1052-9. PubMed ID: 23831963
[TBL] [Abstract][Full Text] [Related]
20. Sialic acid-binding Ig-like lectin 1 expression in inflammatory and resident monocytes is a potential biomarker for monitoring disease activity and success of therapy in systemic lupus erythematosus.
Biesen R; Demir C; Barkhudarova F; Grün JR; Steinbrich-Zöllner M; Backhaus M; Häupl T; Rudwaleit M; Riemekasten G; Radbruch A; Hiepe F; Burmester GR; Grützkau A
Arthritis Rheum; 2008 Apr; 58(4):1136-45. PubMed ID: 18383365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
